Acmecilin Injection 500 mg/vial

Acmecilin Injection, manufactured by ACME Laboratories Ltd, contains Ampicillin Sodium 500 mg/vial as a potent antibiotic. Priced at ৳27.20 per vial with a 5’s pack costing ৳136.00, it treats bacterial infections in respiratory, gastrointestinal, and genitourinary systems. This injection requires proper storage (20-25°C) and careful reconstitution for optimal efficacy.

The medication works by inhibiting bacterial cell wall synthesis, effective against E. coli, Salmonella, and nonpenicillinase-producing organisms. Dosage varies: adults receive 500 mg–2 g based on infection severity, while children under 10 get half doses. Intravenous administration is critical for meningitis (150 mg/kg daily for children). Always consult healthcare providers for personalized regimens.

Common side effects include nausea, diarrhea, and skin rashes. Severe reactions like anaphylaxis or Stevens-Johnson syndrome require immediate medical attention. Avoid combining with oral contraceptives or warfarin due to reduced efficacy. Pregnant women (Category B) should use under medical supervision. Overdose management focuses on symptom relief and hemodialysis if necessary.

LSI keywords like Acmecilin Injection uses and Ampicillin Sodium price highlight its therapeutic role. For alternatives, explore Acmecilin 250 mg/vial or consult physicians for ampicillin substitutes. ACME Laboratories ensures quality compliance, making this injection a trusted choice in Bangladesh’s healthcare landscape.

IV Adults: 2g every 6 hrs for meningitis. Pediatrics: 150 mg/kg/day. Renal impairment requires dose adjustment. Administer IV injections over 3-5 minutes. Treatment duration varies from 5 days for UTIs to 14 days for typhoid.

Nausea, vomiting, diarrhoea, erythematous maculo-papular rashes, sore mouth, black/hairy tongue, rash, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema, fever, joint pains, serum sickness-like symptoms, haemolytic anaemia, thrombocytopenia, leucopenia, neutropenia, coagulation disorders, prolonged bleeding time and prothrombin time, CNS toxicity (e.g. convulsions); paraesthesia, nephropathy, interstitial nephritis, hepatitis, cholestatic jaundice, moderate and transient increase in transaminases, Anaphylaxis, Clostridium difficile-associated diarrhoea (CDAD).

Pregnancy Category B. Breastfeeding: Caution advised—excreted in milk; monitor infant for adverse effects.

Perform allergy testing in sensitive patients. Monitor renal function in impairment. Complete full course. Report persistent diarrhea immediately.

Pediatrics: Half dose for <10 years. Geriatrics: Assess renal function. Renal impairment: Dose adjustment needed if CrCl<10. Hepatic impairment: Use with caution.

Symptoms: Nausea, vomiting and diarrhoea.
Management: Symptomatic and supportive treatment. May be removed from the circulation by haemodialysis.